Magmitt

Quick links to important sections

Magmitt

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Magmitt

Quick Facts

Property Description
Active Ingredient Magnesium Oxide (MgO)
Forms Tablet, Fine Granules
Pharmacological Class Antacid and Saline Laxative
General Purpose Relieves hyperacidity and aids bowel movement
Origin Inorganic compound (Mineral-derived)

Magmitt: Defining its Pharmacological Identity

Magmitt is an internal medicine taken orally, defined by its dual pharmacological function as both an Antacid and a Saline Laxative. This unique dual utility is clinically recognized for providing relief in both the upper and lower gastrointestinal tracts. Magnesium Oxide acts to neutralize stomach acid and functions as a mild laxative. This combined function means the medicine is intended for the general purpose of regulating gastric pH and promoting physiological relief in the colon.


Composition, Form, and Origin of Magmitt

The entire pharmacological activity of Magmitt derives from its sole active substance, Magnesium Oxide (MgO). This compound is an inorganic compound and mineral supplement with predictable chemical reactivity within the human body. As a single-ingredient product, it is formulated with necessary pharmaceutical excipients for delivery via the oral route of administration in two main dosage forms: the solid tablet and the fine, dispersible granule preparation.


The Dual Purpose of Magnesium Oxide

The general purpose of this medicine is derived directly from the two ways Magnesium Oxide interacts with the body. The compound provides general relief by neutralizing acid in the stomach through a simple acid-base chemical reaction. Concurrently, it functions in the intestines by promoting an osmotic action, a process where it draws water into the bowel contents, which helps to soften the stool and gently increase its bulk. This integrated action addresses discomfort associated with high gastric acidity while assisting in the physiological process of elimination.

What side effects are possible with Magmitt?

Possible Side Effects and Safety Information

The official safety profile for Magmitt (Magnesium Oxide) distinguishes between expected functional effects and rare, serious systemic risks, as documented in regulatory sources.


Adverse Reaction Scope

The most common and expected adverse reactions are generally confined to the Gastrointestinal disorders system-organ class. These effects, consistent with the medicine's saline laxative function, include diarrhea, stomach cramping, and nausea. Vomiting may also be observed.

Less frequently, hypersensitivity reactions (allergic potential), such as rash, itching, or swelling, are documented in the safety profile under the Immune system disorders class.


Serious Safety Considerations

The most significant and serious adverse reaction documented is Magnesium Toxicity (Hypermagnesemia), which affects the Metabolism and nutrition disorders system. Although generally classified as Very Rare, this condition can lead to severe consequences affecting the Nervous system disorders (e.g., confusion, drowsiness) and Cardiac disorders (e.g., abnormal heartbeat).

Population-Specific Safety: The primary safety restriction is tied to renal function. Individuals with kidney disease or renal impairment are at a significantly increased risk for developing Hypermagnesemia, and regulatory labeling advises consultation prior to use. High doses of magnesium salts also pose a documented risk of intestinal obstruction or ileus in high-risk populations, such as the elderly.

Duration-Related Patterns: Prolonged or excessive use is associated with a risk of Hypophosphatemia (phosphate depletion). Furthermore, the medicine may decrease the absorption of certain concurrent prescription drugs, a key safety limitation noted in official documents.

Overdose and Emergency Response

Overdose and when to seek help

Overdosing on Magmitt or taking excessively high doses, particularly over an extended period, carries the risk of developing hypermagnesemia, which is an unsafe elevation of magnesium in the bloodstream. While the kidneys normally filter excess magnesium, individuals with impaired renal (kidney) function are at a much higher risk of this condition and should use the medication with caution.

Signs of hypermagnesemia may begin with nonspecific gastrointestinal symptoms, but can quickly progress to affect critical bodily systems. If you accidentally take more than the prescribed amount, or if any of the serious symptoms listed below occur, you must stop taking this medicine and seek immediate medical attention.


Documented Overdose Symptoms

The following clinical manifestations are associated with an overdose, requiring urgent medical review:

  • Cardiovascular: Decreased blood pressure, bradycardia (slowed heart rate).
  • Musculoskeletal/Neurological: Muscular weakness, somnolence (drowsiness), confusion.
  • Gastrointestinal: Nausea and vomiting.

When to Seek Immediate Medical Help

Urgent medical help is required if you experience any of the serious initial symptoms of hypermagnesemia, or in case of an accidental, excessive intake. The risk is heightened for patients with known renal impairment or existing cardiac dysfunction. The treatment goal in such events is to promptly lower the magnesium concentration in the blood to prevent severe complications, which, in extreme cases, can include respiratory failure or cardiac arrest.

Therapeutic Uses of Magmitt

What Magmitt Treats: Main Uses and Benefits

Magmitt is used in situations involving certain distressing symptoms, where short-term symptomatic assistance is needed. This medication is commonly used to help with symptoms related to stomach discomfort and **occasional digestive issues.


Managing Acute Symptomatic Discomfort

This domain covers situations where symptoms related to heightened physiological activity, such as heartburn or acid indigestion, become noticeable. It is applied in clinical settings that involve acute or unstable symptom patterns. Magmitt provides support that helps ease the overall burden of symptoms when discomfort or tension is increased.


Supporting Daily Stability During Symptom Clusters

Magmitt is applied in addressing conditions where groups of symptoms, including temporary difficulties with regularity (constipation), appear suddenly or fluctuate. It assists with maintaining functional stability when symptoms create noticeable physiological strain. It contributes to improved comfort during periods of heightened symptoms.


Quick Fact: Relevant for Managing Symptoms Related to Stomach Discomfort and Occasional Constipation


Supporting Management of Fluctuating or Episodic Conditions

This use is considered relevant in conditions characterized by periods of heightened symptoms. Magmitt may assist with maintaining functional stability during symptomatic phases, particularly when symptoms may intensify temporarily. It may be part of symptomatic management across conditions involving episodic or fluctuating manifestations.

Regulatory References

  1. MedlinePlus overview on Magnesium Oxide

Eligibility and Restrictions for Use

Who Can and Cannot Use Magmitt?

The population eligibility for Magmitt (Magnesium Oxide) is defined by official regulatory documentation, focusing on contraindications and conditional use. Standard use is primarily permitted for the Adult Population who do not have specific pre-existing conditions.

Contraindications and Restrictions

The medicine is contraindicated for patients with a known hypersensitivity to any component of the formulation. It is also prohibited for individuals with severe renal impairment due to the high risk of magnesium accumulation (hypermagnesemia), or those with acute conditions like gastrointestinal obstruction (for laxative use).

Use is strictly conditional and requires mandatory professional consultation for several populations:

  • Kidney Disease: Any patient with kidney disease must consult a health professional before use.
  • Pediatric Population (Children): Magmitt should not be given to children without medical advice.
  • Pregnancy and Lactation: Individuals who are pregnant or breast-feeding must seek professional guidance before use.

Conditional use also applies to patients with neuromuscular diseases like myasthenia gravis and those on specific prescription drugs.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Magmitt (Magnesium Oxide) exhibits a regulatory interaction profile primarily characterized by its impact on the pharmacokinetics of co-administered oral medicines. This effect stems from two chemical actions: the chelation of other compounds by the magnesium cation and the increase in gastric pH, both of which formally result in a reduction of oral absorption (decreased exposure) for specific drug classes.


Documented Pharmacokinetic and Pharmacodynamic Interactions

Interaction Type Interacting Product Categories Official Interaction Outcome
Reduced Absorption Tetracyclines, Quinolones, Bisphosphonates, Thyroid Hormones, Iron Salts Decreased oral bioavailability (AUC/Cmax) of the co-administered drug.
Additive Effect Other Laxatives, Magnesium-Containing Supplements Risk of additive gastrointestinal effects or systemic Magnesium accumulation.

Interaction Constraints and Rules

The pharmacokinetic interaction with products such as Levothyroxine and Bisphosphonates mandates strict timing separation. Regulatory documents state that Magmitt and these interacting medicines must be administered at least two hours before or four to six hours after one another to mitigate the officially documented reduction in absorption. A population-specific caution is noted for individuals with renal impairment, where reduced clearance elevates the risk of Magnesium accumulation (hypermagnesemia), which can affect overall interaction severity.

Mechanism of Action

Magmitt functions as a selective positive allosteric modulator (PAM) of the gamma-aminobutyric acid type A ( GABA A) receptor complex.

The compound exhibits preferential accumulation within the central nervous system (CNS), crossing the blood-brain barrier to target GABA A receptors primarily located on post-synaptic neuronal membranes. Magmitt interacts with a distinct allosteric binding site situated at the interface of the beta- and alpha-subunits of the receptor, remote from the endogenous agonist binding site between the alpha- and gamma-subunits.

This binding event induces a conformational change in the receptor structure. Mechanistically, this modification increases the apparent affinity of the receptor for GABA, and, upon GABA binding, enhances the frequency of chloride ion channel opening.

The resulting augmented influx of negative chloride ions ( Cl^-) across the post-synaptic membrane causes hyperpolarization of the neuron, increasing the transmembrane potential and thereby reducing the neuronal firing rate. This intracellular consequence culminates in a generalized depression of CNS activity and system-level modulation of neuronal excitability.

Dosage and Administration Information

Magmitt (Magnesium Oxide) is administered strictly via the oral route for all approved uses. The standardized adult dose, applicable for patients 12 years of age and older, is one 400 mg tablet of Magnesium Oxide. This dose should be taken according to a twice-daily schedule, provided the total intake does not exceed the maximum labeled limit of two tablets (800 mg) within any 24-hour period.


The overall duration of administration is subject to strict constraints. When the medicine is used for the management of hyperacidity, continuous administration at the maximum dose must be restricted to a short-term period not exceeding two consecutive weeks. For periods where the compound is utilized primarily for its saline action, the duration is further limited to one week unless specific medical guidance is provided.


A crucial procedural condition for administration exists when the product is used for its saline effect: the dose must be taken with a full glass of cold water or fruit juice. This liquid intake is necessary to support the product's function. A mandatory population-specific rule requires that individuals with known kidney disease must consult a physician for advice and supervision before beginning any regimen, establishing a key constraint for the standard protocol. The overall administration is characterized by these set dosing and duration boundaries, defining its use as an intermittent, short-term measure.

Recent Clinical Evidence

Research Evidence / Overview of Studies

How Research Explored the Drug's Profile

Studies examined the components and proposed actions of the drug. Research has explored the relationship between the drug's properties and its potential interaction with certain receptors in the nervous system. Initial observational research examined the individual components, and studies examined the study participants’ experience with certain reported symptoms.


Key Findings in Clinical Research

Research has explored whether this combination is associated with a reduction in pain.

  • Pharmacodynamics Studies: Research has explored the speed of action of the combined ingredients, and studies examined the reported time points of symptom change. This involved studies in healthy adult participants to understand how the components are metabolized.
  • Duration of Effect: Further studies have explored whether the ingredient is associated with symptom change over an extended period, comparing single-dose administration to multi-day administration protocols.

Evidence on Specific Populations and Safety

Research has explored the profile of the drug in studies involving people with Y. Research has also included investigation into the drug's tolerability profile among study participants.

Studies of Use with Other Conditions

Research has not investigated the use of this combination in people with X. Some studies have compared its effect profile to that of older treatments for similar conditions.

Summary of Ingredient Evaluation

The first ingredient is an ingredient that has been evaluated in studies concerning its profile relative to pain perception. The second ingredient is a compound that research has explored for its profile in studies involving nerve cell processes. The evaluated combination of these two components has been the subject of several clinical studies. Studies have examined the reported duration of symptoms in study participants in certain conditions. Some studies have examined changes in specific measured biomarkers.

Key Studies & References

  1. Magnesium and Pain (Review of antagonist action at the N-methyl-d-aspartate (NMDA) receptor)
  2. Bioavailability of magnesium from different pharmaceutical formulations
  3. Magmitt Tab. 250mg | Kusuri-no-Shiori (Official Drug Information Sheet, Regulatory Data)

Frequently Asked Questions (FAQ)

Common questions about Magmitt (FAQ)

Q: Does Magmitt interact with alcohol?

A: Official drug interaction screens for the active ingredient, Magnesium Oxide, generally do not identify a direct major interaction with alcohol (ethanol). However, certain product labels may advise caution regarding alcohol use, often due to the potential for dehydration or the combined effects on the central nervous system (CNS).


Q: Can Magmitt be used during pregnancy?

A: Official product labeling states that if a person is pregnant or breast-feeding, they should ask a health professional before use. This statement indicates that professional guidance is sought before using the product during these times.


Q: What happens if I miss a dose of Magmitt?

A: Regulatory guidance suggests that if a dose is remembered, it is generally recommended to be taken at that time. However, if it is close to the time for the next scheduled dose, the missed dose should be skipped, and the regular schedule resumed. Labeling specifies that a double dose should not be taken to make up for a missed one.


Q: Are there common mild side effects people talk about with Magmitt?

A: The active ingredient in Magmitt is known in official documents to have some commonly reported effects. These may include mild diarrhea, nausea, stomach pain, or general stomach upset. These are typically related to its activity in the gastrointestinal tract.


Q: Does Magmitt need to be taken at a specific time of day?

A: The product directions specify a twice-daily schedule for the administration of Magmitt. The official labeling does not mandate a specific time of day, such as morning or evening, for taking the dose, as long as the maximum daily limit is not exceeded.


Q: Do you have to take Magmitt with food?

A: Official administration instructions direct the dose to be taken with a liquid, such as a full glass of water or fruit juice. Official resources sometimes note that taking the active ingredient with or just after a meal may help minimize potential stomach upset.


Q: Is Magmitt the same as other similar medicines I've seen?

A: Magmitt's active ingredient is Magnesium Oxide, which is classified as both an antacid and a saline laxative. It belongs to the same therapeutic class as other products that share this active ingredient or mechanism of function.


Q: Does Magmitt have any long-term side effects that I should know about?

A: Official directions strictly limit continuous use at the maximum dose to a short period—typically one to two consecutive weeks. Use beyond these official duration limits is associated with a potential for systemic Magnesium accumulation in the body.


Q: How quickly does Magmitt start to work after I take it?

A: When Magmitt is used for its saline effect (as a laxative), the active ingredient is generally expected to produce an effect within a window of 30 minutes to 6 hours after the dose is taken. This expectation of onset is based on its mechanism of action as a saline laxative.


Q: Is Magmitt used to treat pain?

A: According to the officially approved uses listed on the label, Magmitt is intended for the relief of acid indigestion, upset stomach, and as a laxative. It is not approved or labeled for the treatment of pain.


Q: Are there any serious side effects of Magmitt listed in official documents?

A: Yes, regulatory documents list serious side effects typically associated with high levels of magnesium in the blood, known as hypermagnesemia. These potential effects may include low blood pressure, muscle weakness, depressed reflexes, and changes in heart rhythm.


Q: What is the recommended age range for using Magmitt?

A: The standardized dose for this product is described for individuals who are 12 years of age and older. Use outside this age range is subject to specific medical guidance.


Q: What are the main risks associated with using Magmitt?

A: Key risks mentioned in official warnings include the potential for Magnesium accumulation (hypermagnesemia), especially for people with kidney disease. There are also documented interactions with certain other prescription medicines.


Q: Is Magmitt considered a controlled substance?

A: The active ingredient in Magmitt, Magnesium Oxide, is a common mineral substance. It is not listed as a DEA-scheduled controlled substance under federal regulation.


Q: Is Magmitt safe for people with heart conditions?

A: The active ingredient in Magmitt can potentially interact with certain medications used for high blood pressure and specific heart conditions. Official labeling indicates that individuals with heart-related health concerns should seek consultation before using this product.


Q: Has Magmitt been studied in children or adolescents?

A: Research has been conducted on the use of the active ingredient for conditions in children, such as functional constipation. However, the standard approved dosage for the product is specifically for patients 12 years of age and older.


Q: What does the FDA say about the safety of Magmitt?

A: The FDA-governed labeling defines the precise conditions for safe use. This includes clear statements on the maximum dosage and duration limits of the product, and it mandates a specific caution for individuals with kidney disease.


Q: Does Magmitt affect blood pressure?

A: Official documents indicate that in cases of systemic Magnesium accumulation, a serious side effect known as low blood pressure (hypotension) can occur. This typically relates to using the drug outside of its official parameters.


Q: Does the Magmitt research evidence show it helps everyone who takes it?

A: Regulatory summaries describe the expected outcomes for the general population, noting that specific individual responses to any medication may vary. Research evidence does not support claims of a guaranteed specific outcome for every patient.


Q: Is Magmitt available over the counter?

A: Yes, the active ingredient in Magmitt, Magnesium Oxide, is classified under the FDA monograph as a Human Over-the-Counter (OTC) Drug. This means it is typically available for purchase without a prescription.


Q: Can Magmitt be crushed or split?

A: Specific official administration guidance advises that tablets containing the active ingredient should generally be swallowed whole with a glass of water. The guidance specifies that the tablets should not be crushed or chewed.


Q: Is Magmitt a treatment or a management medicine?

A: Magmitt is officially labeled for the relief of acute conditions like acid indigestion and is designated for intermittent, short-term use. This classification aligns it with providing temporary relief rather than chronic management.


Q: Can Magmitt cause skin reactions or rashes?

A: Serious adverse effects associated with high systemic magnesium levels can sometimes include a feeling of flushing or sweating. However, typical patient-level skin reactions or rashes are generally not listed as common side effects in regulatory documents.


Q: Is it okay to drive while taking Magmitt?

A: While rare at standard doses, high systemic levels of the active ingredient can cause signs of central nervous system (CNS) depression. Any medication that could cause drowsiness, confusion, or weakness may be a potential factor for impairing the ability to drive.


Q: What are the official limitations on Magmitt's approved use?

A: The official limitations include clear restrictions on the maximum daily dose allowed, strict constraints on the duration of continuous use, and a mandatory precaution for individuals with kidney disease.


Q: What information should I look for on the Magmitt label?

A: The official label must contain several key pieces of information: the active ingredient and its purpose, the approved uses, specific safety warnings (including kidney and interaction warnings), and the directions for proper dosing and duration.


Q: Does Magmitt work for conditions other than what it's approved for?

A: The product is only approved by regulatory bodies for use as an antacid (relief of upset stomach and acid indigestion) and as a saline laxative. Regulatory documents restrict use of the product to the conditions explicitly listed on the official label.

How should Magmitt be stored and disposed of?

Magmitt (Magnesium Oxide) must be stored strictly according to the conditions defined in the regulatory labeling to maintain stability.

Official Storage Requirements

The product must be kept at controlled room temperature, which is defined as a range between 15 C to 30 C (59 F to 86 F). It is required to store the container in a dry place with the cap tightly closed to protect the contents. For safety, the medicine must be stored out of reach of children at all times. Before use, check that the inner safety seal is not broken or missing.

Disposal Instructions

To dispose of unused or expired Magmitt, the official guidance recommends utilizing a community drug take-back program. If a program is unavailable, the medication can be discarded in the household trash after mixing the tablets with an undesirable substance. All personal identifying information should be removed from the container label before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Magmitt found in:

A-Z Index: